105471-98-5 Usage
Uses
Used in Pharmaceutical Applications:
Desrhamnosyl isoacteoside is used as a potential therapeutic agent for its anti-inflammatory and antioxidant activities. It is being studied for its potential to alleviate inflammation and oxidative stress, which are common factors in various diseases and health conditions.
Used in Natural Medicine:
Desrhamnosyl isoacteoside is used as a component in natural medicine formulations, leveraging its bioactive properties to provide health benefits. It is particularly valued for its potential to support the immune system and promote overall well-being.
Used in Drug Development:
Desrhamnosyl isoacteoside is used as a candidate for drug development, with researchers exploring its potential to be incorporated into new medications. Its diverse range of health-related properties makes it an attractive target for the creation of novel therapeutics.
Used in Anticancer Research:
Desrhamnosyl isoacteoside is used as a subject of anticancer research, with studies investigating its potential to inhibit cancer cell growth and proliferation. It is being explored for its possible role in cancer prevention and treatment strategies.
Used in Anti-allergic Applications:
Desrhamnosyl isoacteoside is used as an anti-allergic agent, with its potential to modulate immune responses and reduce allergic reactions being of interest to researchers and practitioners in the field of allergy management.
Check Digit Verification of cas no
The CAS Registry Mumber 105471-98-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,5,4,7 and 1 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 105471-98:
(8*1)+(7*0)+(6*5)+(5*4)+(4*7)+(3*1)+(2*9)+(1*8)=115
115 % 10 = 5
So 105471-98-5 is a valid CAS Registry Number.
105471-98-5Relevant academic research and scientific papers
Short synthesis of phenylpropanoid glycosides calceolarioside-B and eutigoside-A
Khong, Duc Thinh,Judeh, Zaher M.A.
, p. 109 - 111 (2016/12/23)
A convenient 4-step synthesis of calceolarioside-B 1 and eutigoside-A 2 in high overall yield is described. The key step involved the regioselective, Me2SnCl2-catalyzed O-6 acylation of unprotected 2-phenylethyl-β-D-glucosides 5a–b with cinnamoyl chlorides 6a–b in excellent yields. Acylation at O-6 is selective with the acid chlorides used. This work serves as a model for the convenient synthesis of phenylpropanoid glycosides acylated at O-6.
A general synthetic strategy and the anti-proliferation properties on prostate cancer cell lines for natural phenylethanoid glycosides
Mulani, Shaheen K.,Guh, Jih-Hwa,Mong, Kwok-Kong Tony
, p. 2926 - 2937 (2014/05/06)
A general strategy for the synthesis of phenylethanoid glycosides (PhG) including echinacoside 1, acteoside 2, calceolarioside-A 3 and calceolarioside-B 4 is reported. The strategy features the application of low substrate concentration glycosylation and N-formyl morpholine modulated glycosylation methods for the construction of 1,2-trans β- and α-glycosidic bonds. The reported strategy does not invoke the use of the participatory acyl protecting function, which is incompatible with the ester function present in target PhG compounds. A preliminary study of the anti-proliferation properties of the PhG compounds 1-4 was performed; the acteoside 2 exhibited the best inhibition on the prostatic cancer cell proliferation. This journal is the Partner Organisations 2014.
